Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $37.65 | 1 | 72.2% |
| Food and Beverage | $14.52 | 1 | 27.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $37.65 | 1 | $0 (2017) |
| ABBVIE INC. | $14.52 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $14.52 | 1 | ABBVIE INC. ($14.52) |
| 2017 | $37.65 | 1 | Shire North American Group Inc ($37.65) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2023 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: EYE CARE | ||||||
| 01/26/2017 | Shire North American Group Inc | XIIDRA (Drug) | Education | In-kind items and services | $37.65 | General |
| Category: OPTHALMICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,254 | 2,431 | $654,066 | $356,212 |
| 2022 | 15 | 1,422 | 2,893 | $739,895 | $413,502 |
| 2021 | 14 | 1,657 | 3,232 | $809,468 | $459,230 |
| 2020 | 14 | 1,631 | 3,345 | $874,609 | $482,864 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 27 | 372 | $455,700 | $257,354 | 56.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 413 | 714 | $78,816 | $41,166 | 52.2% |
| 67028 | Injection of drug into eye | Office | 2023 | 33 | 210 | $26,040 | $17,990 | 69.1% |
| 92134 | Imaging of retina | Office | 2023 | 317 | 576 | $41,520 | $16,186 | 39.0% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 143 | 152 | $14,396 | $6,614 | 45.9% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 70 | 79 | $11,860 | $6,576 | 55.5% |
| 92133 | Imaging of optic nerve | Office | 2023 | 177 | 253 | $16,740 | $5,979 | 35.7% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 29 | 29 | $5,179 | $2,597 | 50.1% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 29 | 29 | $3,016 | $1,290 | 42.8% |
| 92025 | Ct scan of cornea | Office | 2023 | 16 | 17 | $799.00 | $458.72 | 57.4% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 22 | 380 | $466,210 | $273,682 | 58.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 438 | 794 | $87,593 | $46,704 | 53.3% |
| 67028 | Injection of drug into eye | Office | 2022 | 33 | 251 | $31,374 | $22,262 | 71.0% |
| 92134 | Imaging of retina | Office | 2022 | 356 | 691 | $49,800 | $20,345 | 40.9% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 18 | 35 | $27,825 | $15,284 | 54.9% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 67 | 73 | $10,794 | $6,511 | 60.3% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 152 | 160 | $15,040 | $6,441 | 42.8% |
| 92133 | Imaging of optic nerve | Office | 2022 | 188 | 265 | $17,490 | $6,387 | 36.5% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 14 | 19 | $7,258 | $5,045 | 69.5% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 33 | 34 | $6,134 | $3,564 | 58.1% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 12 | 63 | $11,340 | $3,328 | 29.4% |
| 92002 | New patient problem focused exam of visual system | Office | 2022 | 37 | 38 | $3,952 | $1,825 | 46.2% |
| 76519 | Ultrasound scan to determine eye length and lens power | Office | 2022 | 21 | 58 | $3,707 | $1,488 | 40.1% |
| 92025 | Ct scan of cornea | Office | 2022 | 17 | 18 | $846.00 | $529.92 | 62.6% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 14 | 14 | $532.00 | $106.23 | 20.0% |
About Dr. Marta King, MD
Dr. Marta King, MD is a Ophthalmology healthcare provider based in Miles City, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861594970.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marta King, MD has received a total of $52.17 in payments from pharmaceutical and medical device companies, with $14.52 received in 2023. These payments were reported across 2 transactions from 2 companies. The most common payment nature is "Education" ($37.65).
As a Medicare-enrolled provider, King has provided services to 5,964 Medicare beneficiaries, totaling 11,901 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Miles City, MT
- Active Since 09/01/2006
- Last Updated 02/22/2008
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1861594970
Products in Payments
- XIIDRA (Drug) $37.65
- LUMIGAN (Drug) $14.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.